1 Market Overview
1.1 Intravenous Human Immunoglobulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Intravenous Human Immunoglobulin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Liquid
1.2.3 Powder
1.3 Market Analysis by Application
1.3.1 Overview: Global Intravenous Human Immunoglobulin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Global Intravenous Human Immunoglobulin Market Size & Forecast
1.4.1 Global Intravenous Human Immunoglobulin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Intravenous Human Immunoglobulin Sales in Volume (2017-2028)
1.4.3 Global Intravenous Human Immunoglobulin Price (2017-2028)
1.5 Global Intravenous Human Immunoglobulin Production Capacity Analysis
1.5.1 Global Intravenous Human Immunoglobulin Total Production Capacity (2017-2028)
1.5.2 Global Intravenous Human Immunoglobulin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Intravenous Human Immunoglobulin Market Drivers
1.6.2 Intravenous Human Immunoglobulin Market Restraints
1.6.3 Intravenous Human Immunoglobulin Trends Analysis
2 Manufacturers Profiles
2.1 Baxter
2.1.1 Baxter Details
2.1.2 Baxter Major Business
2.1.3 Baxter Intravenous Human Immunoglobulin Product and Services
2.1.4 Baxter Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Intravenous Human Immunoglobulin Product and Services
2.2.4 Grifols Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Intravenous Human Immunoglobulin Product and Services
2.3.4 CSL Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Intravenous Human Immunoglobulin Product and Services
2.4.4 Octapharma Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Biotest
2.5.1 Biotest Details
2.5.2 Biotest Major Business
2.5.3 Biotest Intravenous Human Immunoglobulin Product and Services
2.5.4 Biotest Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Kedrion
2.6.1 Kedrion Details
2.6.2 Kedrion Major Business
2.6.3 Kedrion Intravenous Human Immunoglobulin Product and Services
2.6.4 Kedrion Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Hualan Bio
2.7.1 Hualan Bio Details
2.7.2 Hualan Bio Major Business
2.7.3 Hualan Bio Intravenous Human Immunoglobulin Product and Services
2.7.4 Hualan Bio Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 CNBG
2.8.1 CNBG Details
2.8.2 CNBG Major Business
2.8.3 CNBG Intravenous Human Immunoglobulin Product and Services
2.8.4 CNBG Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Shanghai RAAS
2.9.1 Shanghai RAAS Details
2.9.2 Shanghai RAAS Major Business
2.9.3 Shanghai RAAS Intravenous Human Immunoglobulin Product and Services
2.9.4 Shanghai RAAS Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Intravenous Human Immunoglobulin Product and Services
2.10.4 CBPO Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 LFB Group
2.11.1 LFB Group Details
2.11.2 LFB Group Major Business
2.11.3 LFB Group Intravenous Human Immunoglobulin Product and Services
2.11.4 LFB Group Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 BPL
2.12.1 BPL Details
2.12.2 BPL Major Business
2.12.3 BPL Intravenous Human Immunoglobulin Product and Services
2.12.4 BPL Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Tiantan Biological(Sinopharm)
2.13.1 Tiantan Biological(Sinopharm) Details
2.13.2 Tiantan Biological(Sinopharm) Major Business
2.13.3 Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Product and Services
2.13.4 Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Taibang Biologic Group
2.14.1 Taibang Biologic Group Details
2.14.2 Taibang Biologic Group Major Business
2.14.3 Taibang Biologic Group Intravenous Human Immunoglobulin Product and Services
2.14.4 Taibang Biologic Group Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Intravenous Human Immunoglobulin Breakdown Data by Manufacturer
3.1 Global Intravenous Human Immunoglobulin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Intravenous Human Immunoglobulin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Intravenous Human Immunoglobulin
3.4 Market Concentration Rate
3.4.1 Top 3 Intravenous Human Immunoglobulin Manufacturer Market Share in 2021
3.4.2 Top 6 Intravenous Human Immunoglobulin Manufacturer Market Share in 2021
3.5 Global Intravenous Human Immunoglobulin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Intravenous Human Immunoglobulin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Intravenous Human Immunoglobulin Market Size by Region
4.1.1 Global Intravenous Human Immunoglobulin Sales in Volume by Region (2017-2028)
4.1.2 Global Intravenous Human Immunoglobulin Revenue by Region (2017-2028)
4.2 North America Intravenous Human Immunoglobulin Revenue (2017-2028)
4.3 Europe Intravenous Human Immunoglobulin Revenue (2017-2028)
4.4 Asia-Pacific Intravenous Human Immunoglobulin Revenue (2017-2028)
4.5 South America Intravenous Human Immunoglobulin Revenue (2017-2028)
4.6 Middle East and Africa Intravenous Human Immunoglobulin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Intravenous Human Immunoglobulin Sales in Volume by Type (2017-2028)
5.2 Global Intravenous Human Immunoglobulin Revenue by Type (2017-2028)
5.3 Global Intravenous Human Immunoglobulin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Intravenous Human Immunoglobulin Sales in Volume by Application (2017-2028)
6.2 Global Intravenous Human Immunoglobulin Revenue by Application (2017-2028)
6.3 Global Intravenous Human Immunoglobulin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Intravenous Human Immunoglobulin Sales by Type (2017-2028)
7.2 North America Intravenous Human Immunoglobulin Sales by Application (2017-2028)
7.3 North America Intravenous Human Immunoglobulin Market Size by Country
7.3.1 North America Intravenous Human Immunoglobulin Sales in Volume by Country (2017-2028)
7.3.2 North America Intravenous Human Immunoglobulin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Intravenous Human Immunoglobulin Sales by Type (2017-2028)
8.2 Europe Intravenous Human Immunoglobulin Sales by Application (2017-2028)
8.3 Europe Intravenous Human Immunoglobulin Market Size by Country
8.3.1 Europe Intravenous Human Immunoglobulin Sales in Volume by Country (2017-2028)
8.3.2 Europe Intravenous Human Immunoglobulin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Intravenous Human Immunoglobulin Sales by Type (2017-2028)
9.2 Asia-Pacific Intravenous Human Immunoglobulin Sales by Application (2017-2028)
9.3 Asia-Pacific Intravenous Human Immunoglobulin Market Size by Region
9.3.1 Asia-Pacific Intravenous Human Immunoglobulin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Intravenous Human Immunoglobulin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Intravenous Human Immunoglobulin Sales by Type (2017-2028)
10.2 South America Intravenous Human Immunoglobulin Sales by Application (2017-2028)
10.3 South America Intravenous Human Immunoglobulin Market Size by Country
10.3.1 South America Intravenous Human Immunoglobulin Sales in Volume by Country (2017-2028)
10.3.2 South America Intravenous Human Immunoglobulin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Intravenous Human Immunoglobulin Sales by Type (2017-2028)
11.2 Middle East & Africa Intravenous Human Immunoglobulin Sales by Application (2017-2028)
11.3 Middle East & Africa Intravenous Human Immunoglobulin Market Size by Country
11.3.1 Middle East & Africa Intravenous Human Immunoglobulin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Intravenous Human Immunoglobulin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Intravenous Human Immunoglobulin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Intravenous Human Immunoglobulin
12.3 Intravenous Human Immunoglobulin Production Process
12.4 Intravenous Human Immunoglobulin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Intravenous Human Immunoglobulin Typical Distributors
13.3 Intravenous Human Immunoglobulin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Intravenous Human Immunoglobulin Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Intravenous Human Immunoglobulin Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Baxter Basic Information, Manufacturing Base and Competitors
Table 4. Baxter Major Business
Table 5. Baxter Intravenous Human Immunoglobulin Product and Services
Table 6. Baxter Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Grifols Basic Information, Manufacturing Base and Competitors
Table 8. Grifols Major Business
Table 9. Grifols Intravenous Human Immunoglobulin Product and Services
Table 10. Grifols Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. CSL Basic Information, Manufacturing Base and Competitors
Table 12. CSL Major Business
Table 13. CSL Intravenous Human Immunoglobulin Product and Services
Table 14. CSL Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Octapharma Basic Information, Manufacturing Base and Competitors
Table 16. Octapharma Major Business
Table 17. Octapharma Intravenous Human Immunoglobulin Product and Services
Table 18. Octapharma Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Biotest Basic Information, Manufacturing Base and Competitors
Table 20. Biotest Major Business
Table 21. Biotest Intravenous Human Immunoglobulin Product and Services
Table 22. Biotest Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Kedrion Basic Information, Manufacturing Base and Competitors
Table 24. Kedrion Major Business
Table 25. Kedrion Intravenous Human Immunoglobulin Product and Services
Table 26. Kedrion Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 28. Hualan Bio Major Business
Table 29. Hualan Bio Intravenous Human Immunoglobulin Product and Services
Table 30. Hualan Bio Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. CNBG Basic Information, Manufacturing Base and Competitors
Table 32. CNBG Major Business
Table 33. CNBG Intravenous Human Immunoglobulin Product and Services
Table 34. CNBG Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 36. Shanghai RAAS Major Business
Table 37. Shanghai RAAS Intravenous Human Immunoglobulin Product and Services
Table 38. Shanghai RAAS Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. CBPO Basic Information, Manufacturing Base and Competitors
Table 40. CBPO Major Business
Table 41. CBPO Intravenous Human Immunoglobulin Product and Services
Table 42. CBPO Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. LFB Group Basic Information, Manufacturing Base and Competitors
Table 44. LFB Group Major Business
Table 45. LFB Group Intravenous Human Immunoglobulin Product and Services
Table 46. LFB Group Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. BPL Basic Information, Manufacturing Base and Competitors
Table 48. BPL Major Business
Table 49. BPL Intravenous Human Immunoglobulin Product and Services
Table 50. BPL Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Tiantan Biological(Sinopharm) Basic Information, Manufacturing Base and Competitors
Table 52. Tiantan Biological(Sinopharm) Major Business
Table 53. Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Product and Services
Table 54. Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Taibang Biologic Group Basic Information, Manufacturing Base and Competitors
Table 56. Taibang Biologic Group Major Business
Table 57. Taibang Biologic Group Intravenous Human Immunoglobulin Product and Services
Table 58. Taibang Biologic Group Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global Intravenous Human Immunoglobulin Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 60. Global Intravenous Human Immunoglobulin Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in Intravenous Human Immunoglobulin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global Intravenous Human Immunoglobulin Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Intravenous Human Immunoglobulin Production Site of Key Manufacturer
Table 64. Intravenous Human Immunoglobulin New Entrant and Capacity Expansion Plans
Table 65. Intravenous Human Immunoglobulin Mergers & Acquisitions in the Past Five Years
Table 66. Global Intravenous Human Immunoglobulin Sales by Region (2017-2022) & (K Units)
Table 67. Global Intravenous Human Immunoglobulin Sales by Region (2023-2028) & (K Units)
Table 68. Global Intravenous Human Immunoglobulin Revenue by Region (2017-2022) & (USD Million)
Table 69. Global Intravenous Human Immunoglobulin Revenue by Region (2023-2028) & (USD Million)
Table 70. Global Intravenous Human Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 71. Global Intravenous Human Immunoglobulin Sales by Type (2023-2028) & (K Units)
Table 72. Global Intravenous Human Immunoglobulin Revenue by Type (2017-2022) & (USD Million)
Table 73. Global Intravenous Human Immunoglobulin Revenue by Type (2023-2028) & (USD Million)
Table 74. Global Intravenous Human Immunoglobulin Price by Type (2017-2022) & (US$/Unit)
Table 75. Global Intravenous Human Immunoglobulin Price by Type (2023-2028) & (US$/Unit)
Table 76. Global Intravenous Human Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 77. Global Intravenous Human Immunoglobulin Sales by Application (2023-2028) & (K Units)
Table 78. Global Intravenous Human Immunoglobulin Revenue by Application (2017-2022) & (USD Million)
Table 79. Global Intravenous Human Immunoglobulin Revenue by Application (2023-2028) & (USD Million)
Table 80. Global Intravenous Human Immunoglobulin Price by Application (2017-2022) & (US$/Unit)
Table 81. Global Intravenous Human Immunoglobulin Price by Application (2023-2028) & (US$/Unit)
Table 82. North America Intravenous Human Immunoglobulin Sales by Country (2017-2022) & (K Units)
Table 83. North America Intravenous Human Immunoglobulin Sales by Country (2023-2028) & (K Units)
Table 84. North America Intravenous Human Immunoglobulin Revenue by Country (2017-2022) & (USD Million)
Table 85. North America Intravenous Human Immunoglobulin Revenue by Country (2023-2028) & (USD Million)
Table 86. North America Intravenous Human Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 87. North America Intravenous Human Immunoglobulin Sales by Type (2023-2028) & (K Units)
Table 88. North America Intravenous Human Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 89. North America Intravenous Human Immunoglobulin Sales by Application (2023-2028) & (K Units)
Table 90. Europe Intravenous Human Immunoglobulin Sales by Country (2017-2022) & (K Units)
Table 91. Europe Intravenous Human Immunoglobulin Sales by Country (2023-2028) & (K Units)
Table 92. Europe Intravenous Human Immunoglobulin Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe Intravenous Human Immunoglobulin Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe Intravenous Human Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 95. Europe Intravenous Human Immunoglobulin Sales by Type (2023-2028) & (K Units)
Table 96. Europe Intravenous Human Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 97. Europe Intravenous Human Immunoglobulin Sales by Application (2023-2028) & (K Units)
Table 98. Asia-Pacific Intravenous Human Immunoglobulin Sales by Region (2017-2022) & (K Units)
Table 99. Asia-Pacific Intravenous Human Immunoglobulin Sales by Region (2023-2028) & (K Units)
Table 100. Asia-Pacific Intravenous Human Immunoglobulin Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific Intravenous Human Immunoglobulin Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific Intravenous Human Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 103. Asia-Pacific Intravenous Human Immunoglobulin Sales by Type (2023-2028) & (K Units)
Table 104. Asia-Pacific Intravenous Human Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 105. Asia-Pacific Intravenous Human Immunoglobulin Sales by Application (2023-2028) & (K Units)
Table 106. South America Intravenous Human Immunoglobulin Sales by Country (2017-2022) & (K Units)
Table 107. South America Intravenous Human Immunoglobulin Sales by Country (2023-2028) & (K Units)
Table 108. South America Intravenous Human Immunoglobulin Revenue by Country (2017-2022) & (USD Million)
Table 109. South America Intravenous Human Immunoglobulin Revenue by Country (2023-2028) & (USD Million)
Table 110. South America Intravenous Human Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 111. South America Intravenous Human Immunoglobulin Sales by Type (2023-2028) & (K Units)
Table 112. South America Intravenous Human Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 113. South America Intravenous Human Immunoglobulin Sales by Application (2023-2028) & (K Units)
Table 114. Middle East & Africa Intravenous Human Immunoglobulin Sales by Region (2017-2022) & (K Units)
Table 115. Middle East & Africa Intravenous Human Immunoglobulin Sales by Region (2023-2028) & (K Units)
Table 116. Middle East & Africa Intravenous Human Immunoglobulin Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa Intravenous Human Immunoglobulin Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa Intravenous Human Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 119. Middle East & Africa Intravenous Human Immunoglobulin Sales by Type (2023-2028) & (K Units)
Table 120. Middle East & Africa Intravenous Human Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 121. Middle East & Africa Intravenous Human Immunoglobulin Sales by Application (2023-2028) & (K Units)
Table 122. Intravenous Human Immunoglobulin Raw Material
Table 123. Key Manufacturers of Intravenous Human Immunoglobulin Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Intravenous Human Immunoglobulin Typical Distributors
Table 127. Intravenous Human Immunoglobulin Typical Customers
List of Figures
Figure 1. Intravenous Human Immunoglobulin Picture
Figure 2. Global Intravenous Human Immunoglobulin Revenue Market Share by Type in 2021
Figure 3. Liquid
Figure 4. Powder
Figure 5. Global Intravenous Human Immunoglobulin Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Specialty Clinic
Figure 8. Others
Figure 9. Global Intravenous Human Immunoglobulin Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Intravenous Human Immunoglobulin Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Intravenous Human Immunoglobulin Sales (2017-2028) & (K Units)
Figure 12. Global Intravenous Human Immunoglobulin Price (2017-2028) & (US$/Unit)
Figure 13. Global Intravenous Human Immunoglobulin Production Capacity (2017-2028) & (K Units)
Figure 14. Global Intravenous Human Immunoglobulin Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Intravenous Human Immunoglobulin Market Drivers
Figure 16. Intravenous Human Immunoglobulin Market Restraints
Figure 17. Intravenous Human Immunoglobulin Market Trends
Figure 18. Global Intravenous Human Immunoglobulin Sales Market Share by Manufacturer in 2021
Figure 19. Global Intravenous Human Immunoglobulin Revenue Market Share by Manufacturer in 2021
Figure 20. Intravenous Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Intravenous Human Immunoglobulin Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Intravenous Human Immunoglobulin Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Intravenous Human Immunoglobulin Sales Market Share by Region (2017-2028)
Figure 24. Global Intravenous Human Immunoglobulin Revenue Market Share by Region (2017-2028)
Figure 25. North America Intravenous Human Immunoglobulin Revenue (2017-2028) & (USD Million)
Figure 26. Europe Intravenous Human Immunoglobulin Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Intravenous Human Immunoglobulin Revenue (2017-2028) & (USD Million)
Figure 28. South America Intravenous Human Immunoglobulin Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Intravenous Human Immunoglobulin Revenue (2017-2028) & (USD Million)
Figure 30. Global Intravenous Human Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 31. Global Intravenous Human Immunoglobulin Revenue Market Share by Type (2017-2028)
Figure 32. Global Intravenous Human Immunoglobulin Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 34. Global Intravenous Human Immunoglobulin Revenue Market Share by Application (2017-2028)
Figure 35. Global Intravenous Human Immunoglobulin Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Intravenous Human Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 37. North America Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 38. North America Intravenous Human Immunoglobulin Sales Market Share by Country (2017-2028)
Figure 39. North America Intravenous Human Immunoglobulin Revenue Market Share by Country (2017-2028)
Figure 40. United States Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Intravenous Human Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 44. Europe Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 45. Europe Intravenous Human Immunoglobulin Sales Market Share by Country (2017-2028)
Figure 46. Europe Intravenous Human Immunoglobulin Revenue Market Share by Country (2017-2028)
Figure 47. Germany Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Intravenous Human Immunoglobulin Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Intravenous Human Immunoglobulin Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Intravenous Human Immunoglobulin Revenue Market Share by Region (2017-2028)
Figure 56. China Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Intravenous Human Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 63. South America Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 64. South America Intravenous Human Immunoglobulin Sales Market Share by Country (2017-2028)
Figure 65. South America Intravenous Human Immunoglobulin Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Intravenous Human Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Intravenous Human Immunoglobulin Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Intravenous Human Immunoglobulin Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Intravenous Human Immunoglobulin in 2021
Figure 77. Manufacturing Process Analysis of Intravenous Human Immunoglobulin
Figure 78. Intravenous Human Immunoglobulin Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer